ZIOPHARM Oncology, Inc. Appoints Michael G. King, Jr. as Senior Vice President of Corporate Development & Communication

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that it has appointed Michael G. King, Jr., Senior Vice President of Corporate Development and Communication. In this newly established position, Mr. King will direct the Company’s communication efforts and work together with the senior management team to advance the Company’s corporate development strategy.
MORE ON THIS TOPIC